Abstract. Gestational diabetes mellitus (GDM), one of the most common pregnancy complications, is defi ned as glucose intolerance with onset or
INTRODUCTION
T he etiology of GDM is multifactorial and has not entirely been elucidated yet. Because of the increased prevalence, understanding the risk factors gains highlighted importance. Obesity (Body Mass Index, BMI > 30), race, family history of diabetes mellitus (especially in fi rst-degree relatives), age older than 25 years, history of GDM in a previous pregnancy, polycystic ovarian syndrome are of major importance for the disease development [1] . Gestational diabetes has a natural course similar to that of type 2 diabetes (T2DM) with characterization by two main pathogenic factors: insulin resistance (IR) and an insulin secretion defect -a woman's pancreatic function is not suffi cient to overcome the diabetogenic environment of pregnancy, thus leading to high blood glucose levels [2] . Different variables and unchangeable factors, affecting the size of IR, pancreatic B-cell dysfunction, and glucose homeostasis, are the subject of study in respect of risk and prevention of GDM and T2DM, considered to be two faces of the same disease. The overweight, obesity, and age during pregnancy are the main modifi able risk factors for GDM, but identifi cation of others is also of special interest [3] .
Deeper knowledge on vitamin D status and the essential trace elements iron, copper, zinc and selenium as potentially modifi able risk factors of GDM and T2DM could assist the elaboration of prevention strategy with impact also on screening, diagnosis and subsequent treatment modalities of these diseases.
IRON
Iron has a dual nature in the human body. It is essential for life with a role in many metabolic processes as oxygen transport, cell growth, and differentiation, regulation of gene expression. On the other hand, the excess iron is highly toxic because it promotes oxidative stress. Recent knowledge determines hepcidin, a peptide hormone produced in the liver, as a key regulator of systemic iron homeostasis [4] . Hepcidin inhibits iron effl ux to plasma by binding to and inducing the degradation of ferroportin, the only known iron exporter present in duodenal enterocytes, reticuloendothelial macrophages, hepatocytes, and placenta. The rate of hepcidin synthesis depends on circulating and stored iron, erythropoietic activity, oxygen tension, and infl ammation. The interplay of these signaling pathways and relative strength of each signal are responsible for hepcidin expression [5] .
Iron overload impairs the response to insulin in the liver, muscle, and adipose tissue [6] . Excess iron, once stored in the liver, interferes with glucose metabolism, causing hyperinsulinemia via both decreased insulin clearance and impaired insulin signaling. Insulin stimulates the intrahepatic iron accumulation by increasing the uptake of diferric transferrin via an enhanced number of transferrin receptors onto the cell surface while upregulating hepcidin expression directly [7] . Iron affects inhibitory effect of insulin on gluconeogenesis, reducing liver extraction and insulin metabolism. Increasing iron stores leads to peripheral hyperinsulinemia with both liver and muscle resistance.
Pregnancy is a unique physiological condition with elevated requirements for micro-and macro-elements. Maintenance of iron homeostasis is critical for mother and developing fetus because both defi ciency and overload impair certain cellular functions. Prophylactic treatment with iron is questionable. Keeping an adequate iron level is important to prevent iron defi ciency anemia with consecutive preterm birth delivery. High maternal hemoglobin as a result of iron supplementation would increase blood viscosity and reduce placental perfusion with adverse pregnancy outcome. Stimulated dietary iron uptake requires particular attention because of iron potential to initiate overproduction of toxic hydroxyl radicals, thus, leading to cell death and oxidative tissue injury [8] .
Recent biomarkers as serum iron, transferrin saturation (TfSat), serum ferritin, soluble transferrin receptors (sTfR), sTfR/ferritin ratio and serum hepcidin characterize complex relationship between iron status and the risk of GDM developing. The link iron  glucose is bidirectional: iron affects glucose metabolism, and glucose metabolism impinges on several iron metabolic pathways [9] . Elevated serum ferritin is associated with impaired glucose tolerance and GDM [10] . It refl ects iron accumulation in body's depots, proposed as a component of insulin resistance syndrome. Additionally, ferritin is an acute phase protein, and pregnancy is a pro-infl ammatory condition. In GDM, this biomarker and BMI are independent predictors of carbohydrate tolerance disturbances in 2 hours Oral Glucose Tolerance Test (OGTT). Ferritin in midpregnancy correlates with a greater risk of GDM, independently of BMI and C-reactive protein (CRP), but no with OGTT results in early postpartum [11] . Increased TfSat, a measure for iron transport in the circulation, is associated with higher risk for GDM [12] .
Infl ammation signifi cantly upregulates hepcidin by the mediation of interleukin-6 (IL-6), and also is responsible for largely increased serum ferritin. Iron, infl ammation or both could be part of ferritin-insulin resistance axis. Other laboratory tests also assess infl ammation: high sensitivity CRP and fi brinogen. CRP at mid-pregnancy correlates with GDM and infl ammation is suggestive of the disease development [13] .
The parameter sTfR refl ects mainly the erythropoietic activity of bone marrow and is less infl uenced by the acute-phase response than ferritin. The data about the connection between sTfR levels in the fi rst trimester and GDM risk is unconvincing. The sTfR/ ferritin ratio offers greater sensitivity and specifi city in the characterization of iron status than measurement of the individual members in the ratio ferritin/ sTfR [14] .
In high-risk pregnancies -associated with the infl ammatory process, obesity and preeclampsia -higher serum hepcidin might cause an iron restriction in the mother, leading to anemia when persisting and to insuffi cient iron supply to the fetus [15] . In contrast, in true iron defi ciency, serum hepcidin is lower than in normal iron status. Elevated hepcidin, signifi cantly related to an increased GDM risk only during the second trimester, has been observed before the diagnosis. Diagnostic utility of serum hepcidin is determined by the possibility of differentiation between true iron defi ciency and functional iron defi ciency in infl ammation. Dynamic measurement of serum concentration of the peptide hormone over the progression of pregnancy, in combination with other parameters of iron status, would optimize trace element supplementation as periods and duration [16] .
COPPER, ZINC, SELENIUM
The bioavailability of essential trace elements during pregnancy is dependent on physiological factors affecting the absorption, transport, and use in the relevant processes [17] . Pregnancy stimulates copper absorption due to increased activity of maternal enzymes -cytochrome oxidase for tissue respiration and superoxide dismutase as part of the antioxidative defense. Increased copper interferes with zinc absorption leading to lower zinc levels. Zinc and selenium demands are stimulated to ensure fetal nutrition. The essential minerals in normal pregnancy, particularly in the third trimester and at birth, are necessary to overcome systemic oxidative, metabolic and infl ammatory stress that would result in a number of adverse conditions: spontaneous abortions, preeclampsia, gestational diabetes mellitus, intrauterine retardation [18] .
Copper (Cu) is not only physiologically important for fetal development but also plays an interactive role in placental iron transport. Recently identifi ed multicopper ferroxidase Zyklopen is involved in iron effl ux from the placenta during iron transfer from mother to fetus. Copper is delivered to the fetus via specifi c placental transporters regulated by estrogen and maternal insulin levels [19] .
Serum Cu and ceruloplasmin levels increase gradually in pregnancy. By the end of pregnancy, serum copper values are two-fold higher than in non-pregnant women. Serum Cu and ceruloplasmin could serve as sensitive indicators for the assessment of the course of pregnancy and placental function [20] . The increase of copper level with the progression of pregnancy may be partially due to the stimulated synthesis of ceruloplasmin, the major copper-binding protein, under the action of estrogen. Ceruloplasmin is an acute phase protein and the pregnancy, as a physiological proinfl ammatory condition, stimulates ceruloplasmin synthesis with a rise in serum copper [21] . The protein has antioxidant properties and is involved in the degradation of highly toxic hydroxyl radicals. The study of the specifi c enzyme activity of ceruloplasmin and copper/ceruloplasmin ratio would provide a more in-depth assessment of copper status in pregnancy in both norm and event pathology [22] . Altered maternal copper levels may contribute to restriction in fetal growth or may lead to preterm delivery or premature rupture of fetal membrane.
Data about serum copper in GDM compared to normal pregnancy are inconsistent. Established significant positive association between fasting serum copper level and fasting serum glucose in GDM indicates that increased copper level could be directly linked to decreased insulin sensitivity [23] . Copper, like iron, is involved in glucose homeostasis as a pro-oxidant factor with the generation of free radicals.
The metabolism of iron and copper is closely interrelated, also in pregnancy. In the mother, iron defi ciency results in an increase of liver copper. Corresponding increases in copper concentration and ceruloplasmin activity are also seen in the maternal serum. Lack of response to iron supplementation in some cases of pregnancy anemia implies at least that some of them could be a consequence of inadequate (low) copper intake. In this situation, the copper status should be considered [24] .
Zinc (Zn) is an essential component of over 1000 proteins  antioxidant enzymes, metalloenzymes, required for carbohydrate and protein metabolism, DNA and RNA synthesis, cellular replication and differentiation, and hormone regulation.
The element mimics and amplifi es the pancreatic and peripheral functions of insulin. Alterations in zinc balance are related to T2DM. Zinc permits the formation of insulin-hexamers in beta-cells and part regulates the beta-cell mass [25] . In other insulin-responsive tissues, i.e. muscle and fat, Zn shows insulinomimetic properties by affecting the insulin receptor signal transduction [26] .
The importance of zinc to fetus growth is demonstrated by the active transport of zinc across the placenta into the fetal circulation resulting in higher cord blood concentrations than in the maternal circulation [27] . The requirement of Zn during the third trimester is approximately twice as high as that in nonpregnant women as a result of progressively decreasing in maternal concentration due to hemodilution and stimulated transfer to growing fetus [28] . Low maternal Zn may be associated with GDM, as well as preeclampsia, gestational hypertension, spontaneous preterm birth and infant birth weight. Selenium (Se) is an integral component of several enzymes: formate dehydrogenase, glutathione peroxidase, selenoprotein P and W and the deiodinase. The element actively participates in the complex antioxidative defense through selenium-dependent glutathione peroxidases (GPXs) and other selenoproteins. Selenium defi ciency is observed in various diseases: diabetes mellitus, heart disease, autoimmune diseases and certain types of cancers [29] . Recently, research focus shifts from the link between Se and T2DM or obesity to Se and GDM. More important, Se might exhibit insulin-like properties, thus, takes part in the maintenance of normal glucose uptake, in the regulation of cellular glucose utilization and in reducing the severity of insulin resistance [30] . In pregnancy, hemodilution and an increased requirement for fetal growth, contribute to selenium depletion. Increasing of insulin resistance occurs in parallel with promotion of oxidative stress, more prominently in GDM. Over-consumption of antioxidants to overcome the oxidative stress could decrease selenium level additionally. Poor status of the trace element would result in aggravation of insulin resistance due to pregnancy, thus, leading to GDM. Some authors report increased selenium concentrations in GDM. In any case, the eventual signifi cant association between serum selenium and GDM has not been evidenced strongly.
Vitamin D
Vitamin D defi ciency is an increasing public health concern. The scientifi c evidence linking vitamin D defi ciency with diabetes is growing large, but data about the relationship between vitamin D status and GDM are still controversial. Vitamin D defi ciency appears to be associated with altered glucose homeostasis during pregnancy [31] . Supplementation with 1,25-dihydroxyvitamin D (1,25(OH)2D) decreases glucose and increases insulin levels.
Normally, maternal physiological insulin resistance supports the fetus to absorb more nutrients. The fi ndings of the link between increased risk of GDM and vitamin D defi ciency are still biologically plausible. The active form of vitamin D-1,25(OH)2D3 regulates circulating glucose levels by modulation of insulin secretion via binding to vitamin D receptor. It promotes insulin sensitivity by stimulating the expression of insulin receptors and enhancing insulin responsiveness for glucose transport. Vitamin D regulates the balance between the extracellular and intracellular calcium pools in b-cell, which is essential for insulinmediated intracellular processes in insulin-responsive tissues. Vitamin D could have an anti-infl ammatory effect in diabetes. Probably, the active form of vitamin D decreases expression of pro-infl ammatory cytokines IL-6 and IL-1 and tumor necrosis factor alpha (TNF-α), involved in insulin resistance [32] . Vitamin D supplementation during pregnancy has benefi cial effects on glycaemia, insulin sensitivity, insulin resistance and metabolic profi les [33] . Placenta has a capacity to synthesize active 1,25(OH)2D linked to the placenta immune-modulatory function [34] . Controversial results exist about the effect of vitamin D on insulin resistance on the base of the relationship between serum total 25(OH)D and homeostatic model assessment HOMA-IR.
The consistent relationship is established between vitamin D defi ciency and increase in GDM development. However, well designed and randomizedcontrolled studies are necessary "to say that vitamin D replacement should be performed to prevent the development of GDM" [35] . A multivariate logistic regression analysis supports the data about vitamin D defi ciency as a signifi cant contributor for GDM (OR 1.387, P = 0.019) [36] . A large meta-analysis with 20 observational studies included reveals an association between maternal vitamin D insuffi ciency and a greater risk of gestational diabetes (RR 1.45; 95 % CI 1.15-1.83; P < 0.001) [37] . Some researchers fail to fi nd a signifi cant connection between vitamin D deficiency and risk of GDM [38] .
Vitamin D and iron defi ciency frequently co-exist. The interplay between iron and vitamin D metabolism may underlie that association. The degree to which molecular mechanisms might mediate these cross-talks has only started to be highlighted, and emerging data suggest that vitamin D affects iron metabolism by modulating erythropoiesis and hepcidin production [39] . In opposite, iron has been shown to modify the expression of fi broblast growth factor 23 (FGF23), the hormone as a key regulator of the renal production of 1,25(OH)2 D [40] .
CONCLUSION
Investigation of the relationships between some essential trace elements and vitamin D status and typical laboratory indicators for women with GDM would contribute to a better understanding of the key role of trace elements and vitamin D for the effects of gestational diabetes as a complex metabolic syndrome, caused by a number of factors -genetic and modifi er.
